News

Articles & Happenings

Press Release – Black Diamond Therapeutics Closes $85 Million Series C Financing

Black Diamond Therapeutics Closes $85 Million Series C Financing Company also announces CRISPR Therapeutics CEO Samarth Kulkarni, Ph.D., Joins its Board of Directors   CAMBRIDGE, Mass. and NEW YORK, December 5, 2019 – Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced the [...]

Press Release – Black Diamond Therapeutics to Present Preclinical Data on its Lead Product Candidate BDTX-189 at the European Society for Medical Oncology 2019

Black Diamond Therapeutics to Present Preclinical Data on its Lead Product Candidate BDTX-189 at the European Society for Medical Oncology 2019   CAMBRIDGE, Mass., and NEW YORK, NY, September 26, 2019 – Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that preclinical [...]

Press Release – Black Diamond Therapeutics Names Christopher Roberts, Ph.D.,
as Chief Scientific Officer

Black Diamond Therapeutics Names Christopher Roberts, Ph.D., as Chief Scientific Officer Industry veteran brings extensive small molecule drug discovery and oncology experience as company advances its MAP platform and moves its lead program, BDTX-189, toward the clinic   Company also announces two new senior appointments in medicinal chemistry and biology   CAMBRIDGE, Mass., and NEW [...]

Press Release – Black Diamond Therapeutics Appoints Thomas Leggett as Chief Financial Officer

Black Diamond Therapeutics Appoints Thomas Leggett as Chief Financial Officer Biotech and pharma industry veteran brings nearly two decades of multi-disciplinary financial experience and proven track record to advance company’s lead programs and MAP platform   CAMBRIDGE, Mass., September 12, 2019 – Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and [...]

Press Release – Black Diamond Therapeutics Appoints Industry Veteran as Chief Operating Officer and General Counsel

Black Diamond Therapeutics Appoints Industry Veteran as Chief Operating Officer and General Counsel   Team also strengthened with key hires in preclinical and clinical development, clinical operations, and finance to drive company’s lead program into the clinic in 2020 and advance its pipeline and MAP platform   CAMBRIDGE, Mass., May 29, 2019 – Black Diamond [...]

Press Release – Black Diamond Therapeutics Presents Data From its Program Targeting Oncogenic Allosteric Mutations in EGFR for Glioblastoma as Late Breaker at the American Association for Cancer Research (AACR) Annual Meeting

Black Diamond Therapeutics Presents Data From its Program Targeting Oncogenic Allosteric Mutations in EGFR for Glioblastoma as Late Breaker at the American Association for Cancer Research (AACR) Annual Meeting   CAMBRIDGE, Mass., March 29, 2019   Black Diamond Therapeutics, Inc., a biotechnology company developing next-generation precision medicines for cancer, today announced that data from its [...]

Press Release – Black Diamond Therapeutics Closes $85 Million Series B Financing

Black Diamond Therapeutics Closes $85 Million Series B Financing Next-wave precision oncology company poised to advance multiple products into clinical development   CAMBRIDGE, Mass., and BASEL, Switzerland, January 10, 2019   Black Diamond Therapeutics, Inc., a biotechnology company developing next-generation precision medicines for cancer, today announced the completion of an oversubscribed Series B financing of [...]

Press Release – Versant Ventures Launches Black Diamond Therapeutics

Versant Ventures Launches Black Diamond Therapeutics Next-wave precision oncology company emerges from Versant’s Ridgeline Discovery Engine   December 11, 2018 Basel, Switzerland, and Toronto, Canada   Black Diamond Therapeutics, a biotechnology company developing a new type of precision medicine for cancer, came out of stealth mode today with a $20 million Series A financing exclusively [...]